{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:42:24Z","timestamp":1765438944799,"version":"3.37.3"},"reference-count":114,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009858","name":"Gabrielle&apos;s Angel Foundation for Cancer Research","doi-asserted-by":"publisher","award":["P23-00364"],"award-info":[{"award-number":["P23-00364"]}],"id":[{"id":"10.13039\/100009858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005968","name":"Leukemia Research Foundation","doi-asserted-by":"publisher","award":["P23-05182"],"award-info":[{"award-number":["P23-05182"]}],"id":[{"id":"10.13039\/100005968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["CA252632","P50 CA171963"],"award-info":[{"award-number":["CA252632","P50 CA171963"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1053\/j.seminhematol.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T16:16:47Z","timestamp":1705508207000},"page":"22-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence"],"prefix":"10.1053","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4688-2478","authenticated-orcid":false,"given":"Simona","family":"Pagliuca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2024.01.002_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0921-8734(95)00007-S","article-title":"The somatic mutation theory of ageing","volume":"338","author":"Morley","year":"1995","journal-title":"Mutat Res"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0002","doi-asserted-by":"crossref","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0003","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.aab4082","article-title":"Somatic mutation in cancer and normal cells","volume":"349","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007108","article-title":"Aging and the rise of somatic cancer-associated mutations in normal tissues","volume":"14","author":"Risques","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2020.06.024","article-title":"Pathogenic mechanisms of somatic mutation and genome mosaicism in aging","volume":"182","author":"Vijg","year":"2020","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0006","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/blood.2022017212","article-title":"CHIP and gout: trained immunity?","volume":"140","author":"Merriman","year":"2022","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0007","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood.2022015384","article-title":"TET2-mutant clonal hematopoiesis and risk of gout","volume":"140","author":"Agrawal","year":"2022","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0008","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0009","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0010","first-page":"1606","article-title":"Clonal hematopoiesis and nonhematologic disorders","volume":"136","author":"Jaiswal","year":"2020","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0011","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1158\/2159-8290.CD-21-0901","article-title":"Clonal hematopoiesis: from mechanisms to clinical intervention","volume":"11","author":"K\u00f6hnke","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0012","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-med-042921-112347","article-title":"Clonal hematopoiesis and its impact on human health","volume":"74","author":"Ahmad","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0013","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0015","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0016","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ng.2271","article-title":"Detectable clonal mosaicism from birth to old age and its relationship to cancer","volume":"44","author":"Laurie","year":"2012","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0017","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.2270","article-title":"Detectable clonal mosaicism and its relationship to aging and cancer","volume":"44","author":"Jacobs","year":"2012","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0019","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00262-008-0515-4","article-title":"Molecular mechanisms of MHC class I abnormalities and APM components in human tumors","volume":"57","author":"Seliger","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-20-0672","article-title":"Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response","volume":"11","author":"Montesion","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0021","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0022","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1399-0039.2004.00324.x","article-title":"Loss of heterozygosity in the HLA class I region in human pancreatic cancer","volume":"64","author":"Ryschich","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<91::AID-IJC17>3.0.CO;2-4","article-title":"Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors","volume":"83","author":"Jim\u00e9nez","year":"1999","journal-title":"Int. J. Cancer."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0024","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/bloodadvances.2017010918","article-title":"Somatic HLA mutations expose the role of class I-mediated autoimmunity in aplastic anemia and its clonal complications","volume":"1","author":"Babushok","year":"2017","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMoa0811036","article-title":"Loss of Mismatched HLA in leukemia after stem-cell transplantation","volume":"361","author":"Vago","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0026","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944872","article-title":"Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond","volume":"13","author":"Pagliuca","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0028","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41375-022-01723-w","article-title":"Molecular landscape of immune pressure and escape in aplastic anemia","volume":"37","author":"Pagliuca","year":"2023","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0029","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/s41467-023-38113-4","article-title":"Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation","volume":"14","author":"Pagliuca","year":"2023","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2012.10.030","article-title":"Antigen processing and presentation: evolution from a bird's eye view","volume":"55","author":"Kaufman","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0031","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev-immunol-051116-052450","article-title":"Unfinished business: evolution of the MHC and the adaptive immune system of jawed vertebrates","volume":"36","author":"Kaufman","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0032","doi-asserted-by":"crossref","first-page":"gkz950","DOI":"10.1093\/nar\/gkz950","article-title":"IPD-IMGT\/HLA database","author":"Robinson","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg2703","article-title":"Origin and evolution of the adaptive immune system: genetic events and selective pressures","volume":"11","author":"Flajnik","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0034","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-065X.1995.tb00670.x","article-title":"A \u201cMinimal Essential Mhc\u201d and an \u201cUnrecognized Mhc\u201d: two extremes in selection for polymorphism","volume":"143","author":"Kaufman","year":"1995","journal-title":"Immunol Rev"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0035","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/molbev\/msy116","article-title":"Divergent allele advantage at human MHC genes: signatures of past and ongoing selection","volume":"35","author":"Pierini","year":"2018","journal-title":"Mol Biol Evol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0036","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41591-019-0639-4","article-title":"Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy","volume":"25","author":"Chowell","year":"2019","journal-title":"Nat Med"},{"issue":"26","key":"10.1053\/j.seminhematol.2024.01.002_bib0037","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1182\/blood.2021012900","article-title":"The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders","volume":"138","author":"Pagliuca","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0038","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00251-017-1017-3","article-title":"A genomic perspective on HLA evolution","volume":"70","author":"Meyer","year":"2018","journal-title":"Immunogenetics"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005111","article-title":"HLA class-II associated HIV polymorphisms predict escape from CD4+ T cell responses","volume":"11","author":"Erdmann","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000131","article-title":"Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations","volume":"17","author":"Manczinger","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0041","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.1812548116","article-title":"HIV peptidome-wide association study reveals patient-specific epitope repertoires associated with HIV control","volume":"116","author":"Arora","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0042","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41467-018-03857-x","article-title":"Ancient DNA study reveals HLA susceptibility locus for leprosy in medieval Europeans","volume":"9","author":"Krause-Kyora","year":"2018","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0043","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1073\/pnas.1722600115","article-title":"Adaptive value of novel MHC immune gene variants","volume":"115","author":"Lenz","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0044","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.tig.2020.01.008","article-title":"Advances in the Evolutionary Understanding of MHC Polymorphism","volume":"36","author":"Radwan","year":"2020","journal-title":"Trends Genet"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41439-022-00226-5","article-title":"Human leukocyte antigen super-locus: nexus of genomic supergenes, SNPs, indels, transcripts, and haplotypes","volume":"9","author":"Kulski","year":"2022","journal-title":"Hum Genome Var"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0046","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"Shukla","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0047","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2016-11-752378","article-title":"Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia","volume":"129","author":"Zaimoku","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0048","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFN\u03b3 and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0049","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cell.2018.08.048","article-title":"Evolutionary pressure against MHC class II binding cancer mutations","volume":"175","author":"Pyke","year":"2018","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0050","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cell.2017.09.050","article-title":"MHC-I genotype restricts the oncogenic mutational landscape","volume":"171","author":"Marty","year":"2017","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0051","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0052","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1038\/s41467-020-20260-7","article-title":"An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0053","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.humimm.2005.10.011","article-title":"Frequent HLA class I loss is an early event in cervical carcinogenesis","volume":"66","author":"Vermeulen","year":"2005","journal-title":"Hum. Immunol."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0054","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00251-006-0111-8","article-title":"LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas","volume":"58","author":"Maleno","year":"2006","journal-title":"Immunogenetics"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2141.2004.05151.x","article-title":"Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas","volume":"127","author":"Dr\u00e9nou","year":"2004","journal-title":"Br J Haematol."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0056","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0167-5699(00)01692-3","article-title":"Antigen-processing machinery breakdown and tumor growth","volume":"21","author":"Seliger","year":"2000","journal-title":"Immunol Today."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0057","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00262-008-0515-4","article-title":"Molecular mechanisms of MHC class I abnormalities and APM components in human tumors","volume":"57","author":"Seliger","year":"2008","journal-title":"Cancer Immunol Immunotherapy"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0058","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat. Med."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0059","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/j.seminoncol.2012.09.009","article-title":"Genomic loss of mismatched human leukocyte antigen and leukemia immune escape from haploidentical graft-versus-leukemia","volume":"39","author":"Vago","year":"2012","journal-title":"Semin. Oncol."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0060","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1093\/carcin\/bgu215","article-title":"MICA polymorphism: biology and importance in cancer","volume":"35","author":"Chen","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0061","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","article-title":"Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding","volume":"169","author":"Salih","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0062","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116427118","article-title":"Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes","volume":"118","author":"Ferraro","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0063","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ccell.2020.06.002","article-title":"Immunogenomic landscape of hematological malignancies","volume":"38","author":"Dufva","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0064","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.3390\/jcm11216574","article-title":"Filling the gap: the immune therapeutic armamentarium for relapsed\/refractory hodgkin lymphoma","volume":"11","author":"Hazane Leroyer","year":"2022","journal-title":"J Clin Med"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0065","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/10428194.2023.2215614","article-title":"Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?","volume":"64","author":"Gurnari","year":"2023","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0066","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1182\/blood.2021012895","article-title":"HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia","volume":"138","author":"Zaimoku","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944872","article-title":"Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond","volume":"13","author":"Pagliuca","year":"2022","journal-title":"Front Immunol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0068","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/sj.leu.2405045","article-title":"In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML","volume":"22","author":"Liso","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0069","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2011-11-394395","article-title":"Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia","volume":"120","author":"Greiner","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0070","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI97482","article-title":"Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia","volume":"129","author":"van der Lee","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0071","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1155\/2013\/582569","article-title":"Mutation of NPM1 and FLT3 genes in acute myeloid leukemia and their association with clinical and immunophenotypic features","volume":"35","author":"Chauhan","year":"2013","journal-title":"Dis Markers"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0072","doi-asserted-by":"crossref","first-page":"14885","DOI":"10.3390\/ijms232314885","article-title":"Comprehensive transcriptomic analysis of VISTA in acute myeloid leukemia: insights into its prognostic value","volume":"23","author":"Pagliuca","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0073","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood.V81.5.1369.1369","article-title":"Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml\/RAR alpha present in acute promyelocytic leukemia cells","volume":"81","author":"Gambacorti-Passerini","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0074","first-page":"1042","article-title":"Murine acute promyelocytic leukemia cells can be recognized and cleared in vivo by adaptive immune mechanisms","volume":"90","author":"Pollock","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0076","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa1808777","article-title":"Immune escape of relapsed AML cells after allogeneic transplantation","volume":"379","author":"Christopher","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0077","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/2643-3230.BCD-21-0050","article-title":"Genetic and transcriptional contributions to relapse in normal karyotype acute myeloid leukemia","volume":"3","author":"Petti","year":"2022","journal-title":"Blood Cancer Discov"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0078","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","article-title":"CTLA-4 can function as a negative regulator of T cell activation","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0079","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1073\/pnas.012583299","article-title":"Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation","volume":"99","author":"Kiick","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0081","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0082","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100991","article-title":"Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment","volume":"57","author":"Serroukh","year":"2023","journal-title":"Blood Reviews"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0084","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/leu.2012.77","article-title":"Expression of CD200 on AML blasts directly suppresses memory T-cell function","volume":"26","author":"Coles","year":"2012","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0085","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/leu.2015.62","article-title":"The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse","volume":"29","author":"Coles","year":"2015","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0086","doi-asserted-by":"crossref","first-page":"E6192","DOI":"10.1073\/pnas.1611723113","article-title":"Antigen exposure shapes the ratio between antigen-specific Tregs and conventional T cells in human peripheral blood","volume":"113","author":"Su","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0087","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2022.05.006","article-title":"Clonal hematopoiesis: Mutation-specific adaptation to environmental change","volume":"29","author":"Florez","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0088","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1152\/physrev.00031.2021","article-title":"Trained immunity: adaptation within innate immune mechanisms","volume":"103","author":"Dom\u00ednguez-Andr\u00e9s","year":"2023","journal-title":"Physiol Rev"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0089","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0090","doi-asserted-by":"crossref","unstructured":"J. Scott Beeler et al., Plasma proteomic signature predicts risk of myeloid neoplasm, (n.d.). Blood (2023) 142 (Supplement 1): 940. 10.1182\/blood-2023-190857 https:\/\/ash.confex.com\/ash\/2023\/webprogram\/Paper190857.html.","DOI":"10.1182\/blood-2023-190857"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0091","doi-asserted-by":"crossref","first-page":"eabm4945","DOI":"10.1126\/sciadv.abm4945","article-title":"The genetic determinants of recurrent somatic mutations in 43,693 blood genomes","volume":"9","author":"Weinstock","year":"2023","journal-title":"Sci Adv."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0092","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2109965","article-title":"Severe aplastic anemia working party of the european society for blood and marrow transplantation, eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault de Latour","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0093","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20112738","article-title":"Cancer immunoediting by the innate immune system in the absence of adaptive immunity","volume":"209","author":"O'Sullivan","year":"2012","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0094","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/bjh.15443","article-title":"Advances in understanding the pathogenesis of acquired aplastic anaemia","volume":"182","author":"Luzzatto","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0095","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1182\/blood.2020010586","article-title":"HLA class I allele-lacking leukocytes predict rare clonal evolution to MDS\/AML in patients with acquired aplastic anemia","volume":"137","author":"Hosokawa","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0096","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41375-022-01636-8","article-title":"Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia","volume":"36","author":"Groarke","year":"2022","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0097","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00665","article-title":"Role of HLA adaptation in HIV evolution","volume":"6","author":"Kl\u00f8verpris","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0098","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1074-7613(00)80553-1","article-title":"Nef interacts with the \u03bc subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules","volume":"8","author":"Gall","year":"1998","journal-title":"Immunity"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0099","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nm0396-338","article-title":"Endocytosis of major histocompatibility complex class I molecules is induced by the HIV\u20131 Nef protein","volume":"2","author":"Schwartz","year":"1996","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0100","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.immuni.2012.09.005","article-title":"HIV and HLA class I: an evolving relationship","volume":"37","author":"Goulder","year":"2012","journal-title":"Immunity"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0101","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1053\/j.gastro.2014.01.054","article-title":"Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions","volume":"146","author":"Kang","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0102","doi-asserted-by":"crossref","first-page":"eabl8881","DOI":"10.1126\/sciimmunol.abl8881","article-title":"HLA-E\u2013restricted SARS-CoV-2\u2013specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation","volume":"8","author":"Yang","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0103","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/s41467-018-07825-3","article-title":"Impaired immune surveillance accelerates accumulation of senescent cells and aging","volume":"9","author":"Ovadya","year":"2018","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0104","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/2159-8290.CD-22-0528","article-title":"Senescence rewires microenvironment sensing to facilitate antitumor immunity","volume":"13","author":"Chen","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0105","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrm3823","article-title":"Cellular senescence: from physiology to pathology","volume":"15","author":"Mu\u00f1oz-Esp\u00edn","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0106","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","article-title":"Senolytics improve physical function and increase lifespan in old age","volume":"24","author":"Xu","year":"2018","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0107","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0108","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1101\/gad.343129.120","article-title":"Senescence and the SASP: many therapeutic avenues","volume":"34","author":"Birch","year":"2020","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0109","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","article-title":"Cellular senescence is immunogenic and promotes antitumor immunity","volume":"13","author":"Marin","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12979-020-00187-9","article-title":"Role of immune cells in the removal of deleterious senescent cells","volume":"17","author":"Kale","year":"2020","journal-title":"Immun Ageing"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0111","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-022-01052-1","article-title":"Senescence escaping immunity","volume":"24","author":"Lefkopoulos","year":"2022","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.002_bib0112","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0113","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.it.2009.05.001","article-title":"An evolutionary perspective on the mechanisms of immunosenescence","volume":"30","author":"Shanley","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1053\/j.seminhematol.2024.01.002_bib0114","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00262-015-1750-0","article-title":"Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance","volume":"65","author":"Manser","year":"2016","journal-title":"Cancer Immunol Immunother"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T20:31:31Z","timestamp":1729110691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196324000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0037196324000015"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.01.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}